Flutemetamol (18F) Recruiting Phase 3 Trials for Dementias / Alzheimer's Disease (AD) / Mild Cognitive Impairment (MCI) Diagnostic

IndicationsStatusPurposePhase
RecruitingDiagnostic3
clinicaltrials.gov IdentifierTitleDrugs
NCT02353949Investigating the Clinical Consequences of Flutemetamol-PET-scanning